With 80466.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.7 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.37 whereas the lowest price it dropped to was $1.3. The 52-week range on GNTA shows that it touched its highest point at $10.00 and its lowest point at $1.28 during that stretch. It currently has a 1-year price target of $7.01. Beta for the stock currently stands at 0.58.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GNTA was down-trending over the past week, with a drop of -8.45%, but this was down by -1.52% over a month. Three-month performance dropped to -59.50% while six-month performance fell -65.52%. The stock lost -12.75% in the past year, while it has lost -72.63% so far this year. A look at the trailing 12-month EPS for GNTA yields -0.51 with Next year EPS estimates of -0.61. EPS is expected to grow by 2.99% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -13.19%.
Float and Shares Shorts:
On 2025-12-31, short shares totaled 77875.0, which was 33.000002 higher than short shares on 1764288000. In addition to Mr. Pierluigi Paracchi as the firm’s Co-Founder, Chairman, CEO & GM, Dr. Luigi Naldini M.D., Ph.D. serves as its Co-Founder & Chairman of Scientific Advisory Board.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GNTA since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With GNTA analysts setting a high price target of 6.916018 and a low target of 6.916018, the average target price over the next 12 months is 6.916018. Based on these targets, GNTA could surge 432.0% to reach the target high and rise by 432.0% to reach the target low. Reaching the average price target will result in a growth of 432.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.47986 being high and -$0.47986 being low. For GNTA, this leads to a yearly average estimate of -$0.47986.
